TRIM33 and liver dysplastic nodule: In summary, our findings emphasize the potential of TIF1γ as a multitargeted therapeutic agent for DN, mitigating both renal and muscular complications through direct fibrosis inhibition and indirect myokine‐mediated inter‐organ crosstalk.